BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33334399)

  • 1. Early assessment of the impact of mitigation measures to control COVID-19 in 22 French metropolitan areas, October to November 2020.
    Spaccaferri G; Larrieu S; Pouey J; Calba C; Benet T; Sommen C; Lévy-Bruhl D; Smaili S; Che D; Filleul L; Caserio-Schönemann C; Ait-El-Belghiti F; Haeghebaert S; Desenclos JC; Huiart L; Laporte A; Rolland P
    Euro Surveill; 2020 Dec; 25(50):. PubMed ID: 33334399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common communicable diseases in the general population in France during the COVID-19 pandemic.
    Launay T; Souty C; Vilcu AM; Turbelin C; Blanchon T; Guerrisi C; Hanslik T; Colizza V; Bardoulat I; Lemaître M; Boëlle PY
    PLoS One; 2021; 16(10):e0258391. PubMed ID: 34634090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging epidemiological principles to evaluate Sweden's COVID-19 response.
    Baral S; Chandler R; Prieto RG; Gupta S; Mishra S; Kulldorff M
    Ann Epidemiol; 2021 Feb; 54():21-26. PubMed ID: 33242596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive containment, suppression, and mitigation of covid-19: lessons learnt from eight countries.
    Wu S; Neill R; De Foo C; Chua AQ; Jung AS; Haldane V; Abdalla SM; Guan WJ; Singh S; Nordström A; Legido-Quigley H
    BMJ; 2021 Nov; 375():e067508. PubMed ID: 34840136
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternating quarantine for sustainable epidemic mitigation.
    Meidan D; Schulmann N; Cohen R; Haber S; Yaniv E; Sarid R; Barzel B
    Nat Commun; 2021 Jan; 12(1):220. PubMed ID: 33431866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underdetection of cases of COVID-19 in France threatens epidemic control.
    Pullano G; Di Domenico L; Sabbatini CE; Valdano E; Turbelin C; Debin M; Guerrisi C; Kengne-Kuetche C; Souty C; Hanslik T; Blanchon T; Boëlle PY; Figoni J; Vaux S; Campèse C; Bernard-Stoecklin S; Colizza V
    Nature; 2021 Feb; 590(7844):134-139. PubMed ID: 33348340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of lockdown strategies targeting age groups on the burden of COVID-19 in France.
    Roche B; Garchitorena A; Roiz D
    Epidemics; 2020 Dec; 33():100424. PubMed ID: 33285420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of national and local lockdowns on the control of COVID-19 pandemic: a rapid review.
    Caristia S; Ferranti M; Skrami E; Raffetti E; Pierannunzio D; Palladino R; Carle F; Saracci R; Badaloni C; Barone-Adesi F; Belleudi V; Ancona C;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):60-68. PubMed ID: 33412795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses.
    Mégarbane B; Bourasset F; Scherrmann JM
    J Gen Intern Med; 2021 Sep; 36(9):2731-2738. PubMed ID: 34131877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of lockdown effect on SARS-CoV-2 dynamics through viral genome quantification in waste water, Greater Paris, France, 5 March to 23 April 2020.
    Wurtzer S; Marechal V; Mouchel JM; Maday Y; Teyssou R; Richard E; Almayrac JL; Moulin L
    Euro Surveill; 2020 Dec; 25(50):. PubMed ID: 33334397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis.
    Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes, as at 27 April 2020.
    ;
    Euro Surveill; 2020 Dec; 25(50):. PubMed ID: 33334400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the impact of national and regional lockdowns on the 2020 spring wave of COVID-19 in France.
    Roux J; Massonnaud CR; Colizza V; Cauchemez S; Crépey P
    Sci Rep; 2023 Feb; 13(1):1834. PubMed ID: 36725962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of the Italian exit strategy from COVID-19 lockdown.
    Marziano V; Guzzetta G; Rondinone BM; Boccuni F; Riccardo F; Bella A; Poletti P; Trentini F; Pezzotti P; Brusaferro S; Rezza G; Iavicoli S; Ajelli M; Merler S
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33414277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social distancing measures in the fight against COVID-19 in Brazil: description and epidemiological analysis by state.
    Silva LLSD; Lima AFR; Polli DA; Razia PFS; Pavão LFA; Cavalcanti MAFH; Toscano CM
    Cad Saude Publica; 2020; 36(9):e00185020. PubMed ID: 32965378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.
    Talic S; Shah S; Wild H; Gasevic D; Maharaj A; Ademi Z; Li X; Xu W; Mesa-Eguiagaray I; Rostron J; Theodoratou E; Zhang X; Motee A; Liew D; Ilic D
    BMJ; 2021 Nov; 375():e068302. PubMed ID: 34789505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France.
    Rahi M; Le Pluart D; Beaudet A; Ismaël S; Parisey M; Poey N; Tarhini H; Lescure FX; Yazdanpanah Y; Deconinck L
    BMC Infect Dis; 2021 Aug; 21(1):812. PubMed ID: 34388990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 in Argentina: Lockdown, mobility, and contagion.
    Larrosa JMC
    J Med Virol; 2021 Apr; 93(4):2252-2261. PubMed ID: 33165959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A "No More Waves" strategy for COVID-19 in Canada.
    Morris AM; Mintz JM
    CMAJ; 2021 Jan; 193(4):E132-E134. PubMed ID: 33298403
    [No Abstract]   [Full Text] [Related]  

  • 20. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
    Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Ledinger D; Zachariah C; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013574. PubMed ID: 33959956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.